Cost-Effectiveness of SAPIEN 3 Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in German Severe Aortic Stenosis Patients at Low Surgical Mortality Risk

INTRODUCTION: In the randomized PARTNER 3 trial, transcatheter aortic valve implantation (TAVI) with the SAPIEN 3 device significantly reduced a composite of all-cause death, stroke, and rehospitalization, compared with surgical aortic valve replacement (SAVR), in patients with severe symptomatic ao...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuck, Karl H., Leidl, Reiner, Frankenstein, Lutz, Wahlers, Thorsten, Sarmah, Archita, Candolfi, Pascal, Shore, Judith, Green, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988804/
https://www.ncbi.nlm.nih.gov/pubmed/36622552
http://dx.doi.org/10.1007/s12325-022-02392-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988804/
https://www.ncbi.nlm.nih.gov/pubmed/36622552
http://dx.doi.org/10.1007/s12325-022-02392-y

Ejemplares similares